Press Releases

Date Title and Summary Additional Formats
Toggle Summary Amphastar Pharmaceuticals to Present at the 2016 Piper Jaffray Healthcare Conference
RANCHO CUCAMONGA, Calif., Nov. 28, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the 2016 Piper Jaffray Healthcare Conference on Wednesday, November 30, 2016 at 11:00 a.m. Eastern Time in New York, NY.
View HTML
Toggle Summary Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2016
Reports Net Revenues of $64.2 Million for the Three Months Ended September 30, 2016 RANCHO CUCAMONGA, Calif., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ended September 30, 2016.
View HTML
Toggle Summary Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2016
RANCHO CUCAMONGA, Calif., Oct. 28, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2016 ended September 30, 2016, after the market closes on Tuesday, November 8, 2016, and will hold a conference call to
View HTML
Toggle Summary Amphastar Pharmaceuticals to Present at the 2016 Wells Fargo Healthcare Conference
RANCHO CUCAMONGA, Calif., Sept. 01, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the 2016 Wells Fargo Healthcare Conference on Thursday, September 08, 2016 at 2:20 p.m. Eastern Time in Boston, MA.
View HTML
Toggle Summary Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2016
Reports Net Revenues of $68.0 Million for the Three Months Ended June 30, 2016
View HTML
Toggle Summary Amphastar Pharmaceuticals, Inc. Purchases International Medication Systems (UK) Limited from UCB PHARMA GmbH
RANCHO CUCAMONGA, Calif., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company"), announced today that, through its wholly owned UK subsidiary, Amphastar UK Limited, acquired a UK based corporation, International Medication Systems (UK)
View HTML
Toggle Summary Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2016
RANCHO CUCAMONGA, Calif. , Aug. 01, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2016 ended June 30, 2016 , after the market closes on Monday, August 8, 2016 , and will hold a conference call to
View HTML
Toggle Summary Amphastar Pharmaceuticals to Present at the Jefferies 2016 Healthcare Conference
RANCHO CUCAMONGA, Calif., June 03, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the Jefferies 2016 Healthcare Conference on Tuesday, June 7, 2016 at 2 p.m. Eastern Time in New York, NY.
View HTML
Toggle Summary Amphastar Pharmaceuticals Reports Financial Results for the First Quarter Ended March 31, 2016
Reports Net Revenues of $59.4 Million for the First Quarter Ended March 31, 2016
View HTML
Toggle Summary Amphastar Pharmaceuticals to Present at the 2016 Bank of America Merrill Lynch 19th Annual Health Care Conference
RANCHO CUCAMONGA, Calif., May 06, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the Bank of America Merrill Lynch 19 th Annual Health Care Conference on Thursday, May 12, 2016 at 9:20 a.m.
View HTML

 

Copyright ©2018 Amphastar Pharmaceuticals, Inc.

Privacy      Terms & Conditions

This site is intended for residents of the United States